About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Hepatitis-B Associated Acute Transverse Myelitis Mimicking Syringomyelia

domperidone sirop

domperidone eureka

prednisolon kol

prednisolon bivirkninger sporturfintl.com
Aneesh Basheer, Sudhagar Mookkappan, Vijay Shanmugham, Nagarajan Natarajan
From the Department of General Medicine, Pondicherry Institute of Medical Sciences, Ganapathichettikulam, Kalapet, Pondicherry- 605014, India.
Corresponding Author:
Dr. Aneesh Basheer
Email: basheeraneesh@gmail.com
Received: 10-JAN-2014 Accepted: 27-JAN-2014 Published Online: 20-FEB-2014
DOI: http://dx.doi.org/10.17659/01.2014.0019
Abstract
Acute transverse myelitis is a rare clinical entity characterized by sudden onset of sensori-motor paralysis due to complete spinal cord dysfunction below a definite level, usually on the trunk. It may be precipitated by a number of conditions, especially vaccinations. Though hepatitis B vaccination can result in transverse myelitis, its occurrence following acute hepatitis B infection has never been described. Moreover, transverse myelitis presenting with features of syringomyelia is rare. We report the case of acute transverse myelitis associated with hepatitis B infection, which was clinically misdiagnosed as a syrinx.
Keywords : Myelitis, Transverse, Hepatitis B, Syringomyelia, Hepatitis B vaccines, Vaccination.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Apr 22, 2025